PEAK6 Group
ISEE

PEAK6 Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

PEAK6 Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,716
Closed -$292K – 4832
2016
Q2 		$292K Buy
+5,716
New +$284K ﹤0.01% 2836

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PEAK6 Group's ISEE Position: Q3 2016 in Review

PEAK6 Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2016, closing a stake of 5,716 shares — an estimated $292K sold.

PEAK6 Group first reported a position in ISEE in Q2 2016 and held it in 1 quarter. The position peaked at $292K in Q2 2016. 192 funds tracked by Wall St. Rank hold ISEE as of Q3 2016.

  • PEAK6 Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • PEAK6 Group sold 5,716 IVERIC bio, Inc. Common Stock shares in Q3 2016, an estimated $292K.
  • PEAK6 Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • PEAK6 Group's IVERIC bio, Inc. Common Stock position peaked at $292K in Q2 2016.
  • 192 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2016.

Based on PEAK6 Group's 13F filing for Q3 2016, filed 14 Nov 2016.